ImmuCell (ICCC) Corporation announced that it has selected Olivier te Boekhorst as its next president and CEO. The company anticipates a start date of November 1 for te Boekhorst. te Boekhorst is currently an operating partner at ARCHIMED, and serves as chair of the board of SeqCenter, a Next Generation Sequencing laboratory where he previously served as CEO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCC: